Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have Burkitt's lymphoma or Burkitt's leukemia.
|Leukemia Lymphoma||Biological: filgrastim Drug: cyclophosphamide Drug: cytarabine Drug: doxorubicin hydrochloride Drug: etoposide Drug: ifosfamide Drug: leucovorin calcium Drug: methotrexate Drug: vincristine sulfate Radiation: radiation therapy||Phase 2|
|Study Design:||Masking: Open Label
Primary Purpose: Treatment
|Official Title:||A Clinicopathological Study In Burkitts's And Burkitt-Like Non-Hodgkin's Lymphoma|
- Progression-free survival
- Survival time
|Study Start Date:||November 2008|
|Study Completion Date:||December 2008|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00040690
|Medical Research Council Clinical Trials Unit|
|London, England, United Kingdom, NW1 2DA|
|Study Chair:||Simon Clawson||Medical Research Council|